Huahai convertible bonds trigger optional put back for investors

Zhejiang Huahai Pharmaceutical Co. (SSE:600521) has triggered the seventh optional put back for its "Huahai Convertible Bonds" (110076), allowing bondholders to sell their unconverted bonds back to the company. The put back price is set at 100.30 yuan per bond, which includes current period interest and taxes. The put back period is scheduled from December 22, 2025, to December 26, 2025, with funds to be disbursed on December 31, 2025.

During the put back period, "Huahai Convertible Bonds" will continue to trade but will cease to be convertible into shares. The put back condition was met as the company's stock price closed below 70% of the current conversion price for 30 consecutive trading days between November 2, 2025, and December 12, 2025. This allows bondholders to exercise their right to sell back their bonds, though it is not mandatory.

Investors are cautioned to consider the investment risk, as the current market price of the "Huahai Convertible Bonds" was higher than the put back price as of the last trading day before this announcement. If the total outstanding par value of the convertible bonds falls below 30m yuan due to the put back, trading will continue, but the bonds will cease trading three business days after a subsequent announcement following the end of the put back period.